tRCC cells were also more sensitive to the knockout of KEAP1, which activates NRF2 signaling, than were ccRCC cells (Extended Data Fig. 4c–d). The gene discussed is KEAP1; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.